Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The success rate of Assisted Reproductive Technology (ART) hovers around 30%. Even in successful cases, the incidence of multiple births, due to multiple embryo transfer, and their associated morbidity, is dangerously high. Now a new paper reveals how laser technology is being used to make ART safer and more efficient.

Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos © Nuffield Department of Obstetrics & Gynaecology
Lien Davidson is a DPhil student at the Nuffield Department of Obstetrics & Gynaecology exploring the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos

How laser techniques are helping to overcome infertility 

An estimated one in seven couples experience difficulty conceiving.  Assisted reproductive technology (ART) has been rapidly expanding since the birth of Louise Brown, the first test tube baby, in 1978. Although an increasingly complex array of laboratory skills and procedures have been developed for infertility treatments, the success rate of ART hovers around 30%. Even in successful cases, the incidence of multiple births, due to multiple embryo transfer, and their associated morbidity, is dangerously high.

In an attempt to make ART safer and more efficient, international medical practice is trending towards single embryo transfers and the use of innovative, sophisticated technologies to identify promising gametes and embryos with the highest potential to generate a pregnancy. Laser technology is increasingly being used to accomplish these aims and improve the efficiency of ART. The use of laser technology reduces procedure times and increases consistency and reproducibility of traditional ART techniques such as embryo biopsy and assisted embryo hatching.

 Download full paper here 

Beam me up, baby: exploring the use of lasers in assisted reproductive technologies (Lien M. Davidson, Celine Jones, Tracey Griffiths and Kevin Coward)

ABOUT THE AUTHORS 

Lien Davidson from the Nuffield Department of Obstetrics & Gynaecology is a recent graduate of the MSc in Clinical Embryology and is now a DPhil student in Dr Kevin Coward’s research group, which explores the use of infra-red lasers as an investigative tool for developmental biology and early stage embryos. Celine Jones, Laboratory Manager for the Coward group and for the MSc in Clinical Embryology, has a broad range of research interests including the cellular, biochemical, and molecular mechanisms of oocyte activation. Tracey Griffiths is a Senior Clinical Embryologist with the Oxford Fertility Unit, with special responsibility for training and the Unit’s embryo biopsy service.

Dr Kevin Coward is Director of the Oxford MSc in Clinical Embryology and Principal Investigator in the Nuffield Department of Obstetrics and Gynaecology (University of Oxford). Dr Coward’s research interests include oocyte activation deficiency, male factor infertility, the potential detrimental effects of ART technologies upon gametes, and the development of novel nanoparticle-mediated delivery systems for gametes and embryos. The latest addition to his research portfolio involves the use of lasers in ART and incorporates collaboration with Research Instruments Ltd (Falmouth, Cornwall).

Similar stories

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

Varicose veins are a very common manifestation of chronic venous disease, affecting over 30% of the population in Western countries. In America, chronic venous disease affects over 11 million men and 22 million women aged 40–80 years old. Left untreated it can escalate to multiple health complications including leg ulcers and ultimately amputations. A new international study by Oxford researchers published on 2nd June 2022 in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.

New imaging study could make diagnosing endometriosis quicker, more accurate and reduce the need for invasive surgery.

A new research study launches to investigate whether a 20-minute imaging scan can detect the most common types of endometriosis, which currently require surgery to diagnose.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Endometriosis: pandemic backlog risks making it even harder for women to get help

The COVID-19 pandemic has had a disproportionate and devastating impact on women’s health, according to a report from the Royal College of Obstetricians and Gynaecologists.

Diagnostic test could offer new hope for ME/CFS patients

Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.

MitOX 2022- 8th April

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2022 on Friday 8th April. Our annual conference for researchers with an interest in mitochondria from academia and pharma. This year's event will be 'hybrid', so you can join in-person or virtually!